Neogen Chemicals Q2 results came in late on Sunday night, and the headline is simple: the business grew fast even with its Dahej plant out of action. The specialty chemicals maker (NSE: NEOGEN) reported consolidated revenue of ₹296 crore for the September quarter, up 42% from the same quarter last year, according to its Q2 FY27 press release filed on NSE. EBITDA rose 51% to ₹45 crore.
Profit is the smaller number here. Consolidated net profit was ₹8 crore, which the company says is 144% higher year-on-year, and EPS for the quarter was ₹2.96 (not annualised). The jump looks big mainly because the base was small.
Neogen Chemicals Q2 results: where the growth came from
Two things drove the quarter. The older bromine and lithium specialty chemicals business kept growing on volumes, with the company pointing to its organolithium products finding newer uses. And the battery chemicals arm, Neogen Ionics, scaled up quickly. Its Q2 revenue was ₹37 crore, against ₹5.4 crore in the same quarter last year. That ₹37 crore is included in the ₹296 crore consolidated figure.
Gross profit was ₹133 crore, up 36%. Notice that gross profit grew slower than revenue. The release lists higher feedstock costs, Middle East tensions and supply chain disruptions as headwinds, along with the extra cost of the Dahej rebuild and tolling arrangements.
Why only ₹8 crore of profit on ₹45 crore of EBITDA? Interest and depreciation. Neogen is spending heavily on new capacity, and the release says both costs are elevated because of that capex. It expects interest costs to come down as it repays term debt.
QIP money, insurance claims and a rating upgrade
The balance sheet story matters as much as the quarter. Neogen raised ₹600 crore through its first-ever qualified institutional placement, which it says was oversubscribed 6.5 times. The money is going towards repaying debt and funding growth. (If you want a refresher on how these issues work, our QIP explainer covers it.)
On the Dahej fire, cumulative recoveries so far stand at ₹164 crore: ₹155 crore in on-account insurance payouts and ₹9 crore from salvage. On October 29 the company also accepted a further ₹152 crore claim from the insurer, to be paid later. With that, total claims received or receivable come to ₹316 crore.
CRISIL also moved the outlook on Neogen’s long-term bank facilities and NCDs to Stable from Negative, keeping the rating at CRISIL A-, as per the release.
Expansion plans to track
The board approved doubling the organolithium facility at Patancheru, Telangana, from 300 to 600 tonnes a year, at an estimated cost of up to ₹45 crore. Neogen puts the extra revenue potential at ₹150-200 crore, depending on lithium prices.
The bigger bet is still battery materials. The total project cost for Neogen Ionics’ Dahej Phase 1 and Pakhajan Phase 2 is now ₹1,795 crore, and ₹1,537 crore has already been spent. Dahej Phase 1 is targeted for completion by February 2027 and Pakhajan Phase 2 by March 2027. The company says it expects a substantial scale-up in Q4 FY27 and beyond, and that its full-year guidance remains on track.
For us, the test is whether battery revenue keeps compounding from here and whether interest costs actually fall after the QIP. Those two lines will decide how much of the EBITDA growth reaches shareholders. If you’re reading results like these for the first time, our guide on how to analyse quarterly results walks through each line.
Disclaimer: This article is for information and education only and is not investment advice. Please do your own research or consult a SEBI-registered adviser before making any investment decision.





Leave a Reply
Join the conversation
Commenting is open to registered readers. Sign up with just your email — no password needed, and it takes under a minute.
Sign up to comment Log in